We found that both compounds were able to increase control, SOD1 and TDP-43 fALS MN viability and neurite morphology, and that this rescue was greater than that of riluzole or edaravone, 2 FDA approved drugs for ALS. Here, SOD1 is linked to amyotrophic lateral sclerosis.